Geoff Mcdonough Generation Bio Co. (GBIO) insider trading activity

Geoff Mcdonough is PRESIDENT AND CEO of Generation Bio Co.. Currently has a direct ownership of 1.36 Million shares of GBIO, which is worth approximately $5.53 Million. The most recent transaction as insider was on Jul 15, 2025, when has been sold 1,548 shares (Common Stock) at a price of $0.43 per share, resulting in proceeds of $665. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.36M

1.11% 3M change

2.3% 12M change

Total Value Held $5.53 Million

GEOFF MCDONOUGH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2025	SELL Payment of exercise price or tax liability	$665 $0.43 p/Share	1,548 Reduced 0.11%	1,364,648 Common Stock
Jul 15 2025	BUY Exercise of conversion of derivative security	-	5,273 Added 0.38%	1,366,196 Common Stock
Apr 15 2025	SELL Payment of exercise price or tax liability	$572 $0.37 p/Share	1,548 Reduced 0.11%	1,349,664 Common Stock
Apr 15 2025	BUY Exercise of conversion of derivative security	-	5,274 Added 0.39%	1,351,212 Common Stock
Jan 15 2025	SELL Payment of exercise price or tax liability	$1,626 $0.89 p/Share	1,828 Reduced 0.14%	1,345,938 Common Stock
Jan 15 2025	BUY Exercise of conversion of derivative security	-	5,274 Added 0.39%	1,347,766 Common Stock
Oct 15 2024	SELL Payment of exercise price or tax liability	$3,746 $2.42 p/Share	1,548 Reduced 0.12%	1,337,629 Common Stock
Oct 15 2024	BUY Exercise of conversion of derivative security	-	5,274 Added 0.39%	1,339,177 Common Stock
Jul 15 2024	SELL Payment of exercise price or tax liability	$4,535 $2.93 p/Share	1,548 Reduced 0.12%	1,333,903 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	-	5,274 Added 0.39%	1,335,451 Common Stock
Apr 15 2024	SELL Payment of exercise price or tax liability	$5,727 $3.7 p/Share	1,548 Reduced 0.12%	1,323,458 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	-	5,274 Added 0.4%	1,325,006 Common Stock
Jan 15 2024	SELL Payment of exercise price or tax liability	$29,473 $1.91 p/Share	15,431 Reduced 1.16%	1,319,732 Common Stock
Jan 15 2024	BUY Exercise of conversion of derivative security	-	44,531 Added 3.25%	1,327,042 Common Stock
Oct 15 2023	SELL Payment of exercise price or tax liability	$33,679 $3.24 p/Share	10,395 Reduced 0.8%	1,288,187 Common Stock
Oct 15 2023	BUY Exercise of conversion of derivative security	-	23,437 Added 1.77%	1,298,582 Common Stock
Jul 15 2023	SELL Payment of exercise price or tax liability	$37,978 $5.08 p/Share	7,476 Reduced 0.58%	1,275,145 Common Stock
Jul 15 2023	BUY Exercise of conversion of derivative security	-	23,437 Added 1.79%	1,282,621 Common Stock
Apr 15 2023	SELL Payment of exercise price or tax liability	$30,955 $4.5 p/Share	6,879 Reduced 0.54%	1,256,068 Common Stock
Apr 15 2023	BUY Exercise of conversion of derivative security	-	23,437 Added 1.82%	1,262,947 Common Stock
Jan 15 2023	SELL Payment of exercise price or tax liability	$41,422 $5.1 p/Share	8,122 Reduced 0.65%	1,239,510 Common Stock
Jan 15 2023	BUY Exercise of conversion of derivative security	-	23,438 Added 1.84%	1,247,632 Common Stock
Oct 15 2022	SELL Payment of exercise price or tax liability	$58,316 $5.61 p/Share	10,395 Reduced 0.84%	1,222,329 Common Stock
Oct 15 2022	BUY Exercise of conversion of derivative security	-	23,438 Added 1.87%	1,232,724 Common Stock
Jul 15 2022	SELL Payment of exercise price or tax liability	$101,597 $7.18 p/Share	14,150 Reduced 1.16%	1,209,286 Common Stock

Also insider at

SURF

Surface Oncology, Inc. Healthcare

Director

THRD

Third Harmonic Bio, Inc. Healthcare

Geoff Mcdonough

PRESIDENT AND CEO

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Generation Bio Co. insider buys or sells GBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Generation Bio Co.

Track Activities on GBIO

Account